Trader consensus implies a 75% probability of the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips—by December 31, driven by recent escalations in global outbreaks. In the past month, CDC elevated to Level 2 enhanced precautions for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), chikungunya in Mayotte (March 10), and global polio affecting dozens of countries (March 9), amid updated Level 1 dengue warnings (April 16). These reflect heightened transmission risks from confirmed case surges, including a U.S. measles outbreak exceeding 1,700 cases by early April. Historical patterns show Level 2 alerts often precede Level 3 during sustained multi-disease threats, though model uncertainties and surveillance updates could shift dynamics; watch weekly CDC reports for escalation signals.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트예
$112,110 거래량
$112,110 거래량
2026.12.31
예
$112,110 거래량
$112,110 거래량
2026.12.31
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus implies a 75% probability of the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips—by December 31, driven by recent escalations in global outbreaks. In the past month, CDC elevated to Level 2 enhanced precautions for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), chikungunya in Mayotte (March 10), and global polio affecting dozens of countries (March 9), amid updated Level 1 dengue warnings (April 16). These reflect heightened transmission risks from confirmed case surges, including a U.S. measles outbreak exceeding 1,700 cases by early April. Historical patterns show Level 2 alerts often precede Level 3 during sustained multi-disease threats, though model uncertainties and surveillance updates could shift dynamics; watch weekly CDC reports for escalation signals.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
마켓 개설일: Jan 19, 2026, 3:15 PM ET
거래량
$112,110종료일
2026.12.31마켓 개설일
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus implies a 75% probability of the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips—by December 31, driven by recent escalations in global outbreaks. In the past month, CDC elevated to Level 2 enhanced precautions for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), chikungunya in Mayotte (March 10), and global polio affecting dozens of countries (March 9), amid updated Level 1 dengue warnings (April 16). These reflect heightened transmission risks from confirmed case surges, including a U.S. measles outbreak exceeding 1,700 cases by early April. Historical patterns show Level 2 alerts often precede Level 3 during sustained multi-disease threats, though model uncertainties and surveillance updates could shift dynamics; watch weekly CDC reports for escalation signals.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
거래량
$112,110종료일
2026.12.31마켓 개설일
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus implies a 75% probability of the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips—by December 31, driven by recent escalations in global outbreaks. In the past month, CDC elevated to Level 2 enhanced precautions for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), chikungunya in Mayotte (March 10), and global polio affecting dozens of countries (March 9), amid updated Level 1 dengue warnings (April 16). These reflect heightened transmission risks from confirmed case surges, including a U.S. measles outbreak exceeding 1,700 cases by early April. Historical patterns show Level 2 alerts often precede Level 3 during sustained multi-disease threats, though model uncertainties and surveillance updates could shift dynamics; watch weekly CDC reports for escalation signals.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트
외부 링크에 주의하세요.
외부 링크에 주의하세요.
자주 묻는 질문